Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telpegfilgrastim Phase 2 in Chemotherapy-Induced Neutropenia
NCT02005458Phase 2Completed
- Sponsor
- Xiamen Tebao Biological Engineering Co., Ltd.
- Start
- Dec 2013
- Primary completion
- Mar 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegfilgrastim in chemotherapy-induced neutropenia (CIN), sponsored by Xiamen Tebao Biological Engineering Co., Ltd.. Started Dec 2013; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on NCT02005458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02005458.